In addition, NOP56 expression in stage III-IV HCC patients was significantly higher than that in stage I-II HCC patients, and the differential expression was also observed between low grades and high grades in HCC (Fig. 1C; Fig. S1C). The gene discussed is NOP56; the disease is hepatocellular carcinoma.